What affidea portugal does

Affidea Portugal operates an integrated national network of 28 medical clinics, 4 hospital units, 2 laboratories, and more than 400 clinical analysis collection points, providing diagnostic imaging, clinical pathology, and specialist medical consultations. Founded in March 2007 as the Portuguese arm of the pan-European Affidea Group, the operator serves approximately 1.6 million patients per year with a workforce of around 2,100 professionals and operates through two principal licensed legal entities: IMI - Imagens Médicas Integradas, S.A. and Ecorad - Ecografia e Radiologia, Lda. (acquired in 2023).

The technical footprint centers on conventional and open MRI, multi-slice CT, digital mammography with tomosynthesis, contrast-enhanced MRI, ultrasound, and X-ray. The proprietary Dose Excellence Programme standardizes CT protocols across the network and has delivered an average 40% reduction in radiation dose while preserving diagnostic image quality, earning the EuroSafe Imaging Wall of Stars recognition from the European Society of Radiology. Patient-facing tooling is delivered through the My Affidea web and mobile platform, which supports appointment scheduling and engagement. AI usage is limited to administrative and marketing functions (content drafting, image generation, knowledge retrieval, SEO automation); no AI is deployed in clinical or diagnostic operations.

Revenue is generated through diagnostic imaging, laboratory analysis, and specialist consultations paid via four channels: the Portuguese National Health Service (SNS), private health insurers, occupational and health subsystems, and direct-pay patients. Pricing is not publicly disclosed and varies by contracted subsystem or insurance plan. The business sits within the privately held Affidea Group, which runs 391 centers across 15 European countries with approximately 16,000 employees, ~20 million examinations per year, and ~14 million patients per year, providing group-level scale advantages in procurement, training, and protocol standardization.

Name

affidea portugal

Legal name

Affidea Portugal

Website

https://affidea.pt

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Affidea Portugal operates a nationwide network of 28 clinics, 4 hospital units, 2 laboratories, and 400+ clinical collection points, providing diagnostic imaging, clinical pathology, and specialist consultations to approximately 1.6 million patients annually as part of the pan-European Affidea Group.

Ownership category

akta.pro rank

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Diagnostic Imaging Services: Revenue generated from medical diagnostic imaging services including MRI, CT, mammography, ultrasound, and X-ray examinations. Services are paid through SNS agreements, health insurance reimbursements, and direct patient payments depending on insurance coverage.
2. Clinical Analysis Services: Revenue from laboratory clinical analysis services, sample collection, and pathological analysis across 400+ collection points and 2 laboratories.
3. Medical Consultations: Revenue from specialist medical consultations in various fields including cardiology, gynecology, internal medicine, neurology, vascular surgery, and general practice.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

Affidea Portugal operates a national network providing diagnostic imaging, clinical pathology laboratory testing, and specialist medical consultations across Portugal. The company delivers services through 28 medical clinics, 4 hospital units, 2 laboratories, and over 400 clinical analysis collection points, with a team of approximately 2,100 professionals serving 1,600,000 patients per year.

Product overview

Affidea Portugal operates as an integrated healthcare services network offering diagnostic imaging, laboratory services, and specialist medical consultations across 28 clinics, 4 hospital units, 2 laboratories, and over 400 clinical collection points. The core diagnostic imaging portfolio includes Ecografia (Ultrasound), Mamografia (Mammography) with tomosynthesis capability, Ressonância Magnética (MRI) in both conventional and open formats, and TAC/Tomografia Computadorizada (CT Scan). Supporting services include comprehensive laboratory analyses (Análises Clínicas), preventive health check-ups (Check-Ups), and specialist consultations in cardiology, angiology, neurology, internal medicine, and general/family medicine. The company provides cardiac diagnostics (ECG, echocardiogram, Holter, MAPA), bone densitometry, eco-doppler, panoramic dental imaging, and X-ray services. A digital patient platform (My Affidea) enables appointment scheduling. The company is part of the larger Affidea Group operating 391 centers across 15 European countries.

Differentiator

Problem solved

Functional benefit

Brands

• My Affidea: Mobile application for patient appointments and health management

Products and services

• Ecografia (Ultrasound)

Quantifiable outcome

• 40% average reduction in radiation dose levels in CT examinations across the network
• +3 more outcomes

Named customers2 records

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability5 records

Feature4 records

Partnerships

One partnership is on record.

• SNS (Serviço Nacional de Saúde)coreOthers · 1 March 2007The Portuguese National Health Service partnership enables Affidea to provide diagnostic imaging services within the public healthcare system, with most units having agreements with SNS for various examinations including ultrasound, mammography, and other diagnostic procedures.

Scale indicators13 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Unilabs: Pan-European clinical laboratory and diagnostic services provider competing directly with Affidea in multiple countries. Both operate centralized labs plus extensive collection networks, offering clinical analysis and imaging services to patients, hospitals, and insurers under similar payer models.
• Synlab: Europe's largest medical diagnostics services provider, offering clinical laboratory testing and increasingly diagnostic imaging across 30+ countries. Directly comparable business model of B2B/B2C diagnostic services with health system and insurance contracts.
• Medicover: European healthcare and diagnostic services network operating clinics, laboratories, and hospitals across Central and Eastern Europe. Comparable integrated diagnostics-plus-care model serving both insured and self-pay patients.
• Joaquim Chaves Saúde: Portuguese healthcare group providing clinical analyses, diagnostic imaging, and medical consultations through a network of clinics and collection points. The most direct domestic competitor to Affidea Portugal in lab and imaging services within Portugal.
• RadNet: US-headquartered diagnostic imaging chain operating hundreds of outpatient imaging centers. Directly comparable freestanding imaging-center business model (MRI, CT, mammo, ultrasound) with similar equipment, payer, and referral dynamics.

Broad incumbents

• CUF - Companhia União Farmacêutica: Portugal's largest private healthcare group operating hospitals and outpatient clinics with in-house diagnostic imaging and laboratory services. Overlaps with Affidea in imaging and consultations but is a broader incumbent spanning inpatient care, emergencies, and surgical services.
• Lusíadas Saúde: Portuguese private hospital and outpatient group offering diagnostic imaging, clinical analyses, and specialist consultations as part of integrated hospital service lines. Competes with Affidea for imaging referrals and insured patients but is broader in scope.
• Hospital da Luz: Portuguese private hospital network with substantial diagnostic imaging and outpatient capabilities. Provides overlapping imaging and lab services through owned facilities, competing with Affidea for specialist referrals and self-pay volumes.
• Sonic Healthcare: Global medical diagnostics provider spanning clinical pathology and radiology across Europe, Australia, and the US. Comparable lab-and-imaging service mix at much larger scale; a benchmark for Affidea Group's pan-European expansion trajectory.
• Quest Diagnostics: One of the world's largest clinical laboratory and diagnostic services companies. Comparable business model in routine clinical testing with reference-lab operations, though predominantly US-based; relevant as a scale and operational benchmark for Affidea's lab business.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/undefined

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about affidea portugal